Clinical Trial Update: Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

View source ↗

Summary

A clinical trial investigating anti-HPA antibodies causing neonatal alloimmune thrombocytopenia in Chinese pregnant women; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Alloimmune Thrombocytopenia

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Neonatal Alloimmune Thrombocytopenia | Status: UNKNOWN